Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Breast Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 60 articles: HTML format Text format

Single Articles

May 2019
1. MOROTTI M, Bridges E, Valli A, Choudhry H, et al
   Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer.
   Proc Natl Acad Sci U S A. 2019 May 31. pii: 1818521116.
   PubMed     Text format     Abstract available
   
   
   
2. 
   Correction for Kroger et al., Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
   Proc Natl Acad Sci U S A. 2019 May 28. pii: 1907473116.
   PubMed     Text format    
   
   
   
3. BAI J, Wu K, Cao MH, Yang Y, et al
   SCF(FBXO22) targets HDM2 for degradation and modulates breast cancer cell invasion and metastasis.
   Proc Natl Acad Sci U S A. 2019 May 28. pii: 1820990116.
   PubMed     Text format     Abstract available
   
   
   April 2019
4. VERMA S, Yeddula N, Soda Y, Zhu Q, et al
   BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
   Proc Natl Acad Sci U S A. 2019;116:7363-7370.
   PubMed     Text format     Abstract available
   
   
   
5. SHANBHAG V, Jasmer-McDonald K, Zhu S, Martin AL, et al
   ATP7A delivers copper to the lysyl oxidase family of enzymes and promotes tumorigenesis and metastasis.
   Proc Natl Acad Sci U S A. 2019;116:6836-6841.
   PubMed     Text format     Abstract available
   
   
   March 2019
6. ZHANG J, Goliwas KF, Wang W, Taufalele PV, et al
   Energetic regulation of coordinated leader-follower dynamics during collective invasion of breast cancer cells.
   Proc Natl Acad Sci U S A. 2019 Mar 28. pii: 1809964116.
   PubMed     Text format     Abstract available
   
   
   
7. CROW M, Lim N, Ballouz S, Pavlidis P, et al
   Predictability of human differential gene expression.
   Proc Natl Acad Sci U S A. 2019;116:6491-6500.
   PubMed     Text format     Abstract available
   
   
   
8. KROGER C, Afeyan A, Mraz J, Eaton EN, et al
   Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells.
   Proc Natl Acad Sci U S A. 2019 Mar 25. pii: 1812876116.
   PubMed     Text format     Abstract available
   
   
   
9. 
   Correction for Blasco-Benito et al., Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
   Proc Natl Acad Sci U S A. 2019 Mar 18. pii: 1903209116.
   PubMed     Text format    
   
   
   February 2019
10. CHUANG PK, Hsiao M, Hsu TL, Chang CF, et al
    Signaling pathway of globo-series glycosphingolipids and beta1,3-galactosyltransferase V (beta3GalT5) in breast cancer.
    Proc Natl Acad Sci U S A. 2019;116:3518-3523.
    PubMed     Text format     Abstract available
    
    
    
11. ONDECK MG, Kumar A, Placone JK, Plunkett CM, et al
    Dynamically stiffened matrix promotes malignant transformation of mammary epithelial cells via collective mechanical signaling.
    Proc Natl Acad Sci U S A. 2019;116:3502-3507.
    PubMed     Text format     Abstract available
    
    
    
12. JIA D, Lu M, Jung KH, Park JH, et al
    Elucidating cancer metabolic plasticity by coupling gene regulation with metabolic pathways.
    Proc Natl Acad Sci U S A. 2019;116:3909-3918.
    PubMed     Text format     Abstract available
    
    
    
13. SLEDGE GW
    Targeting CXCR4-induced desmoplasia to improve checkpoint inhibition in breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 22. pii: 1900368116.
    PubMed     Text format    
    
    
    
14. LI X, Gruosso T, Zuo D, Omeroglu A, et al
    Infiltration of CD8(+) T cells into tumor cell clusters in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1817652116.
    PubMed     Text format     Abstract available
    
    
    
15. BLASCO-BENITO S, Moreno E, Seijo-Vila M, Tundidor I, et al
    Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815034116.
    PubMed     Text format     Abstract available
    
    
    
16. KUBLI SP, Bassi C, Roux C, Wakeham A, et al
    AhR controls redox homeostasis and shapes the tumor microenvironment in BRCA1-associated breast cancer.
    Proc Natl Acad Sci U S A. 2019 Feb 7. pii: 1815126116.
    PubMed     Text format     Abstract available
    
    
    January 2019
17. CHEN IX, Chauhan VP, Posada J, Ng MR, et al
    Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer.
    Proc Natl Acad Sci U S A. 2019 Jan 30. pii: 1815515116.
    PubMed     Text format     Abstract available
    
    
    
18. KOBOLD S
    Innate and adaptive immunity combined for cancer treatment.
    Proc Natl Acad Sci U S A. 2019;116:1087-1088.
    PubMed     Text format    
    
    
    
19. ZHANG S, Zhang H, Ghia EM, Huang J, et al
    Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody.
    Proc Natl Acad Sci U S A. 2019 Jan 8. pii: 1816262116.
    PubMed     Text format     Abstract available
    
    
    December 2018
20. TOMINAGA K, Minato H, Murayama T, Sasahara A, et al
    Semaphorin signaling via MICAL3 induces symmetric cell division to expand breast cancer stem-like cells.
    Proc Natl Acad Sci U S A. 2018 Dec 26. pii: 1806851116.
    PubMed     Text format     Abstract available
    
    
    
21. BOCCI F, Gearhart-Serna L, Boareto M, Ribeiro M, et al
    Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.
    Proc Natl Acad Sci U S A. 2018 Dec 26. pii: 1815345116.
    PubMed     Text format     Abstract available
    
    
    
22. KAPLANOV I, Carmi Y, Kornetsky R, Shemesh A, et al
    Blocking IL-1beta reverses the immunosuppression in mouse breast cancer and synergizes with anti-PD-1 for tumor abrogation.
    Proc Natl Acad Sci U S A. 2018 Dec 13. pii: 1812266115.
    PubMed     Text format     Abstract available
    
    
    
23. TOKUYAMA M, Kong Y, Song E, Jayewickreme T, et al
    ERVmap analysis reveals genome-wide transcription of human endogenous retroviruses.
    Proc Natl Acad Sci U S A. 2018;115:12565-12572.
    PubMed     Text format     Abstract available
    
    
    
24. LIU C, Sun L, Yang J, Liu T, et al
    FSIP1 regulates autophagy in breast cancer.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1809681115.
    PubMed     Text format     Abstract available
    
    
    November 2018
25. MATSUNUMA R, Chan DW, Kim BJ, Singh P, et al
    DPYSL3 modulates mitosis, migration, and epithelial-to-mesenchymal transition in claudin-low breast cancer.
    Proc Natl Acad Sci U S A. 2018 Nov 29. pii: 1810598115.
    PubMed     Text format     Abstract available
    
    
    October 2018
26. SUN XX, Chen Y, Su Y, Wang X, et al
    SUMO protease SENP1 deSUMOylates and stabilizes c-Myc.
    Proc Natl Acad Sci U S A. 2018;115:10983-10988.
    PubMed     Text format     Abstract available
    
    
    
27. LIANG W, Li Q, Ferrara N
    Metastatic growth instructed by neutrophil-derived transferrin.
    Proc Natl Acad Sci U S A. 2018;115:11060-11065.
    PubMed     Text format     Abstract available
    
    
    September 2018
28. REESE JM, Bruinsma ES, Nelson AW, Chernukhin I, et al
    ERbeta-mediated induction of cystatins results in suppression of TGFbeta signaling and inhibition of triple-negative breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2018 Sep 26. pii: 1807751115.
    PubMed     Text format     Abstract available
    
    
    
29. GURYEV EL, Volodina NO, Shilyagina NY, Gudkov SV, et al
    Radioactive ((90)Y) upconversion nanoparticles conjugated with recombinant targeted toxin for synergistic nanotheranostics of cancer.
    Proc Natl Acad Sci U S A. 2018;115:9690-9695.
    PubMed     Text format     Abstract available
    
    
    
30. LAN J, Lu H, Samanta D, Salman S, et al
    Hypoxia-inducible factor 1-dependent expression of adenosine receptor 2B promotes breast cancer stem cell enrichment.
    Proc Natl Acad Sci U S A. 2018 Sep 21. pii: 1809695115.
    PubMed     Text format     Abstract available
    
    
    
31. CHU B, He A, Tian Y, He W, et al
    Photoaffinity-engineered protein scaffold for systematically exploring native phosphotyrosine signaling complexes in tumor samples.
    Proc Natl Acad Sci U S A. 2018;115:E8863-E8872.
    PubMed     Text format     Abstract available
    
    
    August 2018
32. ARVANITIS CD, Askoxylakis V, Guo Y, Datta M, et al
    Mechanisms of enhanced drug delivery in brain metastases with focused ultrasound-induced blood-tumor barrier disruption.
    Proc Natl Acad Sci U S A. 2018 Aug 27. pii: 1807105115.
    PubMed     Text format     Abstract available
    
    
    
33. GRITHER WR, Longmore GD
    Inhibition of tumor-microenvironment interaction and tumor invasion by small-molecule allosteric inhibitor of DDR2 extracellular domain.
    Proc Natl Acad Sci U S A. 2018;115:E7786-E7794.
    PubMed     Text format     Abstract available
    
    
    
34. DATTA S, Misra SK, Saha ML, Lahiri N, et al
    Orthogonal self-assembly of an organoplatinum(II) metallacycle and cucurbit[8]uril that delivers curcumin to cancer cells.
    Proc Natl Acad Sci U S A. 2018;115:8087-8092.
    PubMed     Text format     Abstract available
    
    
    
35. FOULDS CE
    Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2018 Aug 6. pii: 1811263115.
    PubMed     Text format    
    
    
    July 2018
36. REN C, Zhang G, Han F, Fu S, et al
    Spatially constrained tandem bromodomain inhibition bolsters sustained repression of BRD4 transcriptional activity for TNBC cell growth.
    Proc Natl Acad Sci U S A. 2018;115:7949-7954.
    PubMed     Text format     Abstract available
    
    
    
37. WANG B, Li D, Kovalchuk I, Apel IJ, et al
    miR-34a directly targets tRNAi(Met) precursors and affects cellular proliferation, cell cycle, and apoptosis.
    Proc Natl Acad Sci U S A. 2018;115:7392-7397.
    PubMed     Text format     Abstract available
    
    
    
38. XIAO T, Li W, Wang X, Xu H, et al
    Estrogen-regulated feedback loop limits the efficacy of estrogen receptor-targeted breast cancer therapy.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1722617115.
    PubMed     Text format     Abstract available
    
    
    
39. LEE JJ, van de Ven RAH, Zaganjor E, Ng MR, et al
    Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3.
    Proc Natl Acad Sci U S A. 2018;115:7057-7062.
    PubMed     Text format     Abstract available
    
    
    June 2018
40. MITTAL S, Yeh K, Leslie LS, Kenkel S, et al
    Simultaneous cancer and tumor microenvironment subtyping using confocal infrared microscopy for all-digital molecular histopathology.
    Proc Natl Acad Sci U S A. 2018;115:E5651-E5660.
    PubMed     Text format     Abstract available
    
    
    
41. SUN X, Wang X, Tang Z, Grivainis M, et al
    Transcription factor profiling reveals molecular choreography and key regulators of human retrotransposon expression.
    Proc Natl Acad Sci U S A. 2018;115:E5526-E5535.
    PubMed     Text format     Abstract available
    
    
    
42. DE SEMIR D, Bezrookove V, Nosrati M, Dar AA, et al
    PHIP as a therapeutic target for driver-negative subtypes of melanoma, breast, and lung cancer.
    Proc Natl Acad Sci U S A. 2018 Jun 4. pii: 1804779115.
    PubMed     Text format     Abstract available
    
    
    May 2018
43. ROY B, Venkatachalapathy S, Ratna P, Wang Y, et al
    Laterally confined growth of cells induces nuclear reprogramming in the absence of exogenous biochemical factors.
    Proc Natl Acad Sci U S A. 2018;115:E4741-E4750.
    PubMed     Text format     Abstract available
    
    
    
44. SEO A, Steinberg-Shemer O, Unal S, Casadei S, et al
    Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1.
    Proc Natl Acad Sci U S A. 2018;115:5241-5246.
    PubMed     Text format     Abstract available
    
    
    
45. LAI X, Stiff A, Duggan M, Wesolowski R, et al
    Modeling combination therapy for breast cancer with BET and immune checkpoint inhibitors.
    Proc Natl Acad Sci U S A. 2018 May 7. pii: 1721559115.
    PubMed     Text format     Abstract available
    
    
    April 2018
46. NAIR P, Vilcek J
    Profile of Alexander Y. Rudensky, winner of the 2018 Vilcek Prize in Biomedical Science.
    Proc Natl Acad Sci U S A. 2018;115:4301-4304.
    PubMed     Text format    
    
    
    
47. VEGA-RUBIN-DE-CELIS S, Zou Z, Fernandez AF, Ci B, et al
    Increased autophagy blocks HER2-mediated breast tumorigenesis.
    Proc Natl Acad Sci U S A. 2018;115:4176-4181.
    PubMed     Text format     Abstract available
    
    
    
48. ZHAO L, Huang S, Mei S, Yang Z, et al
    Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis.
    Proc Natl Acad Sci U S A. 2018;115:E3673-E3681.
    PubMed     Text format     Abstract available
    
    
    March 2018
49. KE H, Zhao L, Zhang H, Feng X, et al
    Loss of TDP43 inhibits progression of triple-negative breast cancer in coordination with SRSF3.
    Proc Natl Acad Sci U S A. 2018 Mar 26. pii: 1714573115.
    PubMed     Text format     Abstract available
    
    
    
50. FLOROS KV, Lochmann TL, Hu B, Monterrubio C, et al
    Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy.
    Proc Natl Acad Sci U S A. 2018;115:E2594-E2603.
    PubMed     Text format     Abstract available
    
    
    February 2018
51. HASHIMOTO K, Ochi H, Sunamura S, Kosaka N, et al
    Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A.
    Proc Natl Acad Sci U S A. 2018;115:2204-2209.
    PubMed     Text format     Abstract available
    
    
    January 2018
52. THU KL, Silvester J, Elliott MJ, Ba-Alawi W, et al
    Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2018 Jan 29. pii: 1719577115.
    PubMed     Text format     Abstract available
    
    
    
53. SAMANTA D, Park Y, Ni X, Li H, et al
    Chemotherapy induces enrichment of CD47(+)/CD73(+)/PDL1(+) immune evasive triple-negative breast cancer cells.
    Proc Natl Acad Sci U S A. 2018 Jan 24. pii: 1718197115.
    PubMed     Text format     Abstract available
    
    
    
54. DEVIGNES CS, Aslan Y, Brenot A, Devillers A, et al
    HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.
    Proc Natl Acad Sci U S A. 2018 Jan 16. pii: 1718009115.
    PubMed     Text format     Abstract available
    
    
    December 2017
55. DOHERTY MR, Cheon H, Junk DJ, Vinayak S, et al
    Interferon-beta represses cancer stem cell properties in triple-negative breast cancer.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1713728114.
    PubMed     Text format     Abstract available
    
    
    November 2017
56. BEAUSANG JF, Wheeler AJ, Chan NH, Hanft VR, et al
    T cell receptor sequencing of early-stage breast cancer tumors identifies altered clonal structure of the T cell repertoire.
    Proc Natl Acad Sci U S A. 2017 Nov 14. pii: 201713863.
    PubMed     Text format     Abstract available
    
    
    
57. 
    Correction for Sansone et al., Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2017 Nov 13. pii: 201718630.
    PubMed     Text format    
    
    
    October 2017
58. BASUDHAR D, Glynn SA, Greer M, Somasundaram V, et al
    Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer.
    Proc Natl Acad Sci U S A. 2017 Oct 27. pii: 201709119.
    PubMed     Text format     Abstract available
    
    
    
59. SANSONE P, Savini C, Kurelac I, Chang Q, et al
    Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer.
    Proc Natl Acad Sci U S A. 2017;114:E9066-E9075.
    PubMed     Text format     Abstract available
    
    
    September 2017
60. HE F, Chiou AE, Loh HC, Lynch M, et al
    Multiscale characterization of the mineral phase at skeletal sites of breast cancer metastasis.
    Proc Natl Acad Sci U S A. 2017 Sep 18. pii: 201708161.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: